Brad Larson

Brad Larson is VP, Project Management at Bionova Scientific, with responsibility for the launch and operation of the GMP biologics drug substance and drug product manufacturing facility.

Prior to joining Bionova, Brad spent over six years with Samsung Biologics in Incheon, South Korea. During his tenure with Samsung, Brad held leadership roles in project management, sales, and business development, leading cross-functional teams, building tools/systems, and consulting directly with clients from kick-off to commercial production. At Samsung, Brad successfully reduced average project timelines by 75% and improved customer satisfaction. He also instituted and led routine deviation review boards to improve deviation management and quality. He advised and guided clients and internal departments in preparation for the first Pre-Approval Inspections (PAI) and follow-up regulatory inspections and responses. Brad has regularly interacted with all major global regulatory agencies throughout his career in both the U.S. and South Korea.

Before joining Samsung Biologics, Brad spent 22+ years with Jubilant HollisterStier (formerly Bayer Corporation then Hollister-Stier) a global CDMO. At Jubilant HollisterStier, Brad held senior leadership roles of increasing responsibilities in Manufacturing, Logistics, and Project Management. He was responsible for building or leading teams, departments, and aseptic manufacturing facilities to support Jubilant’s North American Aseptic Manufacturing and Operations.

Brad earned his B.S. in Botany at Oregon State University in Corvallis, Oregon.